Evidence map›Paper›PMID 15501933›Full record

ArticleBiophysical journal2005

Phosphatidylethanolamine enhances rhodopsin photoactivation and transducin binding in a solid supported lipid bilayer as determined using plasmon-waveguide resonance spectroscopy.

Isabel D Alves, Gilmar F J Salgado, Zdzislaw Salamon, Michael F Brown, Gordon Tollin, Victor J Hruby

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 106 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Magic angle spinning NMR of G protein-coupled receptors.Progress in nuclear magnetic resonance spectroscopy · 2022
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. A novel bisretinoid of retina is an adduct on glycerophosphoethanolamine.Investigative ophthalmology & visual science · 2011
    Article
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Isabel D AlvesDepartment of Biochemistry and Molecular Biophysics, University of Arizona, Tucson, Arizona 85721, USA.
Gilmar F J Salgado
Zdzislaw Salamon
Michael F Brown
Gordon Tollin
Victor J Hruby
University of Arizona · US

Funding

THERAPEUTIC PROFILES OF OPIOID DELTA RECEPTORS--NEW MODALITIESP01DA006284 · NIDA · UNIVERSITY OF ARIZONA · PI HRUBY, VICTOR J · 1989 to 2015
$14.8M
NOVEL NON-PEPTIDE OPIOID LIGANDS FOR PAINR01DA013449 · NIDA · UNIVERSITY OF ARIZONA · PI HRUBY, VICTOR J · 2000 to 2015
$6.8M
MEMBRANE BASIS OF VISUAL EXCITATIONR01EY012049 · NEI · UNIVERSITY OF ARIZONA · PI BROWN, MICHAEL F · 1998 to 2012
$3.3M
LIPID-MEDIATED MEMBRANE PROTEIN INSERTION AND FOLDINGR01GM059630 · NIGMS · UNIVERSITY OF ARIZONA · PI TOLLIN, GORDON · 2001 to 2004
$750k
NEI NIH HHS EY12049NEI NIH HHS R01 EY012049NIDA NIH HHS DA06284NIDA NIH HHS DA13449NIDA NIH HHS P01 DA006284NIDA NIH HHS R01 DA013449NIGMS NIH HHS GM59630NIGMS NIH HHS R01 GM059630
6 · The paper itself

Abstract

Flash photolysis studies have shown that the membrane lipid environment strongly influences the ability of rhodopsin to form the key metarhodopsin II intermediate. Here we have used plasmon-waveguide resonance (PWR) spectroscopy, an optical method sensitive to both mass and conformation, to probe the effects of lipid composition on conformational changes of rhodopsin induced by light and due to binding and activation of transducin (G(t)). Octylglucoside-solubilized rhodopsin was incorporated by detergent dilution into solid-supported bilayers composed either of egg phosphatidylcholine or various mixtures of a nonlamellar-forming lipid (dioleoylphosphatidylethanolamine; DOPE) together with a lamellar-forming lipid (dioleoylphosphatidylcholine; DOPC). Light-induced proteolipid conformational changes as a function of pH correlated well with previous flash photolysis studies, indicating that the PWR spectral shifts monitored metarhodopsin II formation. The magnitude of these effects, and hence the extent of the conformational transition, was found to be proportional to the DOPE content. Our data are consistent with previous suggestions that lipids having a negative spontaneous curvature favor elongation of rhodopsin during the activation process. In addition, measurements of the G(t)/rhodopsin interaction in a DOPC/DOPE (25:75) bilayer at pH 5 demonstrated that light activation increased the affinity for G(t) from 64 nM to 0.7 nM, whereas G(t) affinity for dark-adapted rhodopsin was unchanged. By contrast, in DOPC bilayers the affinity of G(t) for light-activated rhodopsin was only 18 nM at pH 5. Moreover exchange of GDP for GTP gamma S was also monitored by PWR spectroscopy. Only the light-activated receptor was able to induce this exchange which was unaffected by DOPE incorporation. These findings demonstrate that nonbilayer-forming lipids can alter functionally linked conformational changes of G-protein-coupled receptors in membranes, as well as their interactions with downstream effector proteins.

Indexed as

AnimalsBiophysical PhenomenaBiophysicsCattleCell MembraneDetergentsGlucosidesGuanosine 5'-O-(3-Thiotriphosphate)Hydrogen-Ion ConcentrationLightLipid BilayersLipidsPhosphatidylcholinesPhosphatidylethanolaminesProtein BindingProtein Conformation1,2-dioleoyl-glycero-3-phosphatidyl ethanolamine1,2-oleoylphosphatidylcholineDetergentsGlucosidesGuanosine 5'-O-(3-Thiotriphosphate)Lipid BilayersLipidsoctyl-beta-D-glucosidePhosphatidylcholinesphosphatidylethanolaminePhosphatidylethanolaminesRhodopsinTransducin

Identifiers

PMID15501933
PMCPMC1304998
OpenAlexW2140704050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.